Neurocrine Biosciences (NBIX) EPS (Basic): 2009-2020
Historic EPS (Basic) for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $4.38.
- Neurocrine Biosciences' EPS (Basic) rose 138.71% to $0.24 in Q3 2021 from the same period last year, while for Sep 2021 it was $4.75, marking a year-over-year increase of 370.30%. This contributed to the annual value of $4.38 for FY2020, which is 995.00% up from last year.
- Latest data reveals that Neurocrine Biosciences reported EPS (Basic) of $4.38 as of FY2020, which was up 995.00% from $0.40 recorded in FY2019.
- In the past 5 years, Neurocrine Biosciences' EPS (Basic) registered a high of $4.38 during FY2020, and its lowest value of -$1.63 during FY2016.
- Its 3-year average for EPS (Basic) is $1.67, with a median of $0.40 in 2019.
- Its EPS (Basic) has fluctuated over the past 5 years, first slumped by 55.24% in 2016, then soared by 995.00% in 2020.
- Yearly analysis of 5 years shows Neurocrine Biosciences' EPS (Basic) stood at -$1.63 in 2016, then increased by 0.61% to -$1.62 in 2017, then surged by 114.20% to $0.23 in 2018, then surged by 73.91% to $0.40 in 2019, then soared by 995.00% to $4.38 in 2020.